Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Arash GhasemiZahra GhashghaiJafar AkbariJamshid Yazdani-CharatiEbrahim SalehifarSeyed Jalal HosseinimehrPublished in: European journal of clinical pharmacology (2018)
ATV was able to reduce significantly itching, breast edema, and pain in patients during radiotherapy.
Keyphrases
- phase iii
- double blind
- clinical trial
- phase ii
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- chronic pain
- prognostic factors
- pain management
- peritoneal dialysis
- randomized controlled trial
- neuropathic pain
- wound healing
- spinal cord injury
- locally advanced
- spinal cord
- postoperative pain